Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. - Armstrong,PW.; Adams,PX.; Al-Khalidi,HR.; Hamm,C.; Holmes,D.; O'Neill,W.; Todaro,TG.; Vahanian,A.; Werf,F Van de.; Granger,CB. (Am Heart J, 2005)